- Home
- KORE vs ABVC Comparison
KORE vs ABVC Comparison
Compare KORE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- ABVC
- Stock Information
- Founded
- KORE 2003
- ABVC 2015
- Country
- KORE United States
- ABVC United States
- Employees
- KORE N/A
- ABVC N/A
- Industry
- KORE Telecommunications Equipment
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- ABVC Health Care
- Exchange
- KORE Nasdaq
- ABVC Nasdaq
- Market Cap
- KORE 45.0M
- ABVC 52.1M
- IPO Year
- KORE N/A
- ABVC N/A
- Fundamental
- Price
- KORE $4.21
- ABVC $2.82
- Analyst Decision
- KORE Hold
- ABVC
- Analyst Count
- KORE 2
- ABVC 0
- Target Price
- KORE $2.75
- ABVC N/A
- AVG Volume (30 Days)
- KORE 211.4K
- ABVC 88.0K
- Earning Date
- KORE 11-12-2025
- ABVC 11-03-2025
- Dividend Yield
- KORE N/A
- ABVC N/A
- EPS Growth
- KORE N/A
- ABVC N/A
- EPS
- KORE N/A
- ABVC N/A
- Revenue
- KORE $285,636,000.00
- ABVC $797,916.00
- Revenue This Year
- KORE $4.46
- ABVC $735.18
- Revenue Next Year
- KORE $5.94
- ABVC N/A
- P/E Ratio
- KORE N/A
- ABVC N/A
- Revenue Growth
- KORE 0.24
- ABVC 56.52
- 52 Week Low
- KORE $1.10
- ABVC $0.40
- 52 Week High
- KORE $4.88
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- KORE 76.68
- ABVC 45.44
- Support Level
- KORE $3.35
- ABVC $2.75
- Resistance Level
- KORE $3.83
- ABVC $2.98
- Average True Range (ATR)
- KORE 0.29
- ABVC 0.14
- MACD
- KORE 0.07
- ABVC -0.01
- Stochastic Oscillator
- KORE 85.30
- ABVC 22.95
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.